SGLT1 and SGLT2 — Drug Target

All drugs that target SGLT1 and SGLT2 — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

SGLT1 and SGLT2 inhibitor · SGLT2 inhibitor

Phase 3 pipeline (2)

• RT001 · Biojiva LLC · SGLT1 and SGLT2 inhibitor · Diabetes
  RT001 is a small molecule drug that targets the SGLT1 and SGLT2 transporters.
• Sotagliflozin High Dose · University of California, San Diego · SGLT2 inhibitor · Diabetes
  Sotagliflozin is a dual inhibitor of SGLT1 and SGLT2, which helps to reduce glucose reabsorption in the kidneys and intestines.